Articles tagged "Risk factors"

2017 American Transplant Congress
Predictors of Renal Function Compensation in Live Donor Nephrectomy.
J. Choong, H. Ali, A. Ahmed.
Royal Preston Hospital, Preston, United Kingdom; Royal Preston Hospital, Prston, United Kingdom; Royal Preston Hospital, Preston, United Kingdom
Introduction: Renal transplantation is the preferred option for patients with end stage renal disease (ESRD). It provides better quality of life and lower mortality rates…
2017 American Transplant Congress
Is There an Association Between Number of Outpatient Primary Care Visits (OPV) and Outcomes in Kidney Transplantation (KTP)?
A. O'Shea, R. Kalil.
Medicine, University of Iowa Carver College of Medicine, Iowa City, IA; Department of Veterans Affairs, Comprehensive Access and Delivery Research Evaluation (CADRE), Iowa City, IA
Background: Periodic outpatient primary care visits (PCV) after KTP is recommended to achieve optimal outcomes, but annual rates of PCV by KTP recipients is not…
2017 American Transplant Congress
De-Novo Portal Vein Thrombosis After Adult-to-Adult Living Donor Liver Transplantation (LDLT) Does Not Impact on Long-Term Outcome.
I. Linares,¹ N. Goldaracena,¹ R. Rosales,¹ L. De La Maza,¹ J. Echeverri,¹ M. Kaths,¹ D. Kollman,¹ N. Selzner,² S. McCluskey,³ G. Sapisochin,¹ L. Lilly,² P. Greig,¹ M. Bhat,² A. Ghanekar,¹ M. Cattral,¹ I. McGilvray,¹ D. Grant,¹ M. Selzner.¹
¹Department of Surgery, Multi-Organ Transplant Program, Toronto General Hospital, University Health Network, Toronto, ON, Canada; ²Department of Medicine, Multi-Organ Transplant Program, Toronto General Hospital University Health Network, Toronto, ON, Canada; ³Department of Anesthesiology, Toronto General Hospital, University Health Network, Toronto, ON, Canada
Portal vein thrombosis(PVT) after deceased donation has been widely described as a liver transplant complication that can lead to graft failure, high morbidity and mortality.…
2017 American Transplant Congress
Impact of Non-Adherence in a Cohort of Kidney Transplant Recipients.
M. Merino-López,¹ C. Flores-Gama.²
¹National Autonomous University of Mexico, Mexico, Mexico; ²Nephrology, National Institute of Cardiology, Mexico, Mexico
Background: The understanding of the main causes of allograft losts and related factors is a critical in the sucess of kidney transplantation programs.Objective: The aim…
2017 American Transplant Congress
Prolonged Dialysis Prior to Renal Transplantation.
D. Aufhauser Jr,¹ A. Peng,¹ D. Murken,¹ S. Concors,¹ M. Levine.^1,2
¹Surgery, University of Pennsylvania, Philadelphia, PA; ²Surgery, Children's Hospital of Philadelphia, Philadelphia, PA
Introduction: To increase access for patients with delayed transplant referral, the new Kidney Allocation System (KAS) recognizes waiting time from the earlier of dialysis initiation…
2017 American Transplant Congress
The Impact of Scleroderma Diagnosis on Lung Transplant Outcomes: A Single Center's Experience.
H. Memon, A. Frost, E. Graviss, D. Nguyen, A. Goodarzi, N. Sinha.
Medicine, Weill Cornell Medical College, Houston Methodist Hospital, Houston, TX
Patients with scleroderma (SSC) associated restrictive lung disease (RD) and pulmonary hypertension (PH) are often turned down for lung transplant due to associated co-morbidities, particularly…
2017 American Transplant Congress
U.S. Outcomes in Early Liver Transplantation for Alcoholic Hepatitis: Results from the American Consortium of Early Liver Transplantation for Alcoholic Hepatitis (ACCELERATE-AH).
B. Lee,¹ N. Mehta,¹ L. Platt,² G. Im,³ G. Therapondos,⁴ H. Han,⁵ D. Victor,⁶ D. Dronamraju,⁷ I. Hanouneh,⁸ M. Voigt,⁹ M. Rinella,¹⁰ S. Eswaran,¹¹ J. Hause,¹¹ C. Hsu,¹² J. Dodge,¹ Z. Li,² N. Terrault.¹
¹UCSF, SF; ²Johns Hopkins, Baltimore; ³Mt Sinai, NYC; ⁴Ochsner, New Orleans; ⁵USC, LA; ⁶Houston Methodist, Houston; ⁷Maryland, Baltimore; ⁸Cleveland Clinic, Cleveland; ⁹Iowa, Iowa City; ¹⁰Northwestern, Chicago; ¹¹Rush, Chicago; ¹²UPenn, Philadelphia
INTRODUCTIONA Franco-Belgian protocol showed that early liver transplant (LT) in severe alcoholic hepatitis (AH) could improve survival with low incidence of alcohol relapse (AR). Application…
2017 American Transplant Congress
What Are “Normal” CSF Findings in the Non-Infected Brain Dead Organ Donor?
R. Steiner,^1,2 C. Wainaina,² J. Tragaser,² L. Stocks.²
¹Medicine, University of California at San Diego School of Medicine, San Diego, CA; ²Lifesharing Organ Procurement Organization, San Diego, CA
Abnormalities in CSF in deceased organ donors may suggest infection and lead to refusal of organs by transplant centers, particularly if a viral process is…
2017 American Transplant Congress
The Impact of Social Support on Kidney Transplant Listing Decisions: Results from a Discrete Choice Experiment.
K. Ladin,^1,2 J. Emerson,² Z. Butt, E. Gordon, D. Hanto, T. Lavelle.²
¹Occupational Therapy, Tufts University, Medford, MA; ²Public Health and Community Medicine, Tufts University School of Medicine, Boston, MA
Background: Although the Centers for Medicare and Medicaid Services require that social support be used to determine transplant eligibility, guidance is vague and centers vary…
2017 American Transplant Congress
Serum AFP Greater Than 200 ng/ml as a Predictor for Low Survival in Patients with Hepatocelullar Carcinoma Recurrence in a Brazilian Multicentric Study.
I. Boin,¹ M. Possatto,¹ E. Ataide,¹ R. Silva,² R. Silva,² H. Felicio,² L. Amado,³ A. Lima,³ T. Seva-Pereira.¹
¹Unit of Liver Transplantation, State University of Campinas, Campinas, SP, Brazil; ²Digestive Surgery - Liver Transplantation, Faculty of Medicine- São Jose do Rio Preto, Rio Preto, SP, Brazil; ³Digestive Surgery - Liver Transplantation, Faculty of Medicine, Federal University of Minas Gerais, Minas Gerais, Brazil
Introduction: Liver transplantation (LT) is the only potential curative treatment for hepatocellular carcinoma (HCC) with recurrence (HCC-R) diagnosed in 16%. Aim: The objective of this…